Yizhun Intelligent (医准智能)

Name: Yizhun Intelligent (医准智能)
Brand: Yizhun Intelligent (医准智能)

Yizhun Intelligent (医准智能) is AI-assisted medical imaging analysis software that provides detection, quantification, follow-up comparison, and structured reporting across modalities including CT, DR (X-ray), mammography, MRI, and ultrasound.

LinkedIn 13|Web traffic 7K|FTEs 7|HQ Beijing, CN

01Competitive Landscape

Competitive Landscape

| Aspect | Yizhun Intelligent (医准智能) | Infervision (InferRead CT Lung) | United Imaging Intelligence (UII) | |--------|------------------------------|---------------------------------|-----------------------------------| | Starting Price | Not publicly listed (quote-based) | Not publicly listed (enterprise) | Not publicly listed (bundled/enterprise) | | Primary Users | China-based hospitals seeking multi-modality imaging assistance and vendor-reported NMPA-cleared modules | Hospitals that prioritize CT lung CAD with public regulatory documentation for some features | Health systems using United Imaging equipment seeking integrated AI across scanners/platforms | | Key Strength | Vendor-stated broad modality support and end-to-end workflow features | Public regulatory signaling for some CT lung features (e.g., references to regulatory clearances) | Equipment-plus-software ecosystem that can simplify integration for standardized fleets | | Key Weakness | Limited publicly accessible third-party review corpus and limited public security/compliance disclosures | Enterprise procurement complexity and modular focus may require combining vendors for multi-modality needs | Potential vendor lock-in if buyer is not standardized on United Imaging devices | - Direct competitors and their key differentiators - Infervision - Public communications include references to regulatory clearances for specific CT lung features and more published regulatory documentation for select products. - United Imaging Intelligence (UII) - Emphasizes integration within an imaging hardware ecosystem; product materials describe multiple clinical AI applications embedded in scanners. - Other Chinese imaging AI vendors - Differentiation typically relates to breadth of NMPA approvals, integration strength with PACS and modality vendors, regional sales/service footprint, and depth of clinical evidence. - Feature comparison: where Yizhun may excel vs lag - Potential strengths (based on vendor materials) - Broad modality and scenario packaging across CT/DR/mammography and other modalities and stated workflow support for follow-up comparison. - Potential weaknesses - Limited transparency of independent, publicly verifiable performance reporting for specific SKUs/configurations. - Limited evidence of an extensive international regulatory footprint (e.g., FDA/CE) in accessible public materials. - Limited public disclosure of security/compliance documentation (SOC 2/ISO). - Pricing comparison: value proposition vs alternatives - Public pricing is not available; qualitative comparisons suggest trade-offs: - Equipment-vendor AI bundles (e.g., UII) may reduce integration effort but increase dependency on a single vendor. - Best-of-breed module vendors may provide clearer validation for specific tasks but require integration work to achieve multi-modality coverage. - Customer testimonials comparing Yizhun to competitors - Not identified in the public sources reviewed. - Market share and adoption trends - Not reliably quantifiable from public sources in this research. Company/press statements suggest deployment across multiple institutions; these figures were not independently verified.

01Competitive Landscape

Competitive Landscape

Aspect	Yizhun Intelligent (医准智能)	Infervision (InferRead CT Lung)	United Imaging Intelligence (UII)
Starting Price	Not publicly listed (quote-based)	Not publicly listed (enterprise)	Not publicly listed (bundled/enterprise)
Primary Users	China-based hospitals seeking multi-modality imaging assistance and vendor-reported NMPA-cleared modules	Hospitals that prioritize CT lung CAD with public regulatory documentation for some features	Health systems using United Imaging equipment seeking integrated AI across scanners/platforms
Key Strength	Vendor-stated broad modality support and end-to-end workflow features	Public regulatory signaling for some CT lung features (e.g., references to regulatory clearances)	Equipment-plus-software ecosystem that can simplify integration for standardized fleets
Key Weakness	Limited publicly accessible third-party review corpus and limited public security/compliance disclosures	Enterprise procurement complexity and modular focus may require combining vendors for multi-modality needs	Potential vendor lock-in if buyer is not standardized on United Imaging devices

Direct competitors and their key differentiators
- Infervision
  - Public communications include references to regulatory clearances for specific CT lung features and more published regulatory documentation for select products.
- United Imaging Intelligence (UII)
  - Emphasizes integration within an imaging hardware ecosystem; product materials describe multiple clinical AI applications embedded in scanners.
- Other Chinese imaging AI vendors
  - Differentiation typically relates to breadth of NMPA approvals, integration strength with PACS and modality vendors, regional sales/service footprint, and depth of clinical evidence.
Feature comparison: where Yizhun may excel vs lag
- Potential strengths (based on vendor materials)
  - Broad modality and scenario packaging across CT/DR/mammography and other modalities and stated workflow support for follow-up comparison.
- Potential weaknesses
  - Limited transparency of independent, publicly verifiable performance reporting for specific SKUs/configurations.
  - Limited evidence of an extensive international regulatory footprint (e.g., FDA/CE) in accessible public materials.
  - Limited public disclosure of security/compliance documentation (SOC 2/ISO).
Pricing comparison: value proposition vs alternatives
- Public pricing is not available; qualitative comparisons suggest trade-offs:
  - Equipment-vendor AI bundles (e.g., UII) may reduce integration effort but increase dependency on a single vendor.
  - Best-of-breed module vendors may provide clearer validation for specific tasks but require integration work to achieve multi-modality coverage.
Customer testimonials comparing Yizhun to competitors
- Not identified in the public sources reviewed.
Market share and adoption trends
- Not reliably quantifiable from public sources in this research. Company/press statements suggest deployment across multiple institutions; these figures were not independently verified.

Aspect

Yizhun Intelligent (医准智能)

Infervision (InferRead CT Lung)

United Imaging Intelligence (UII)

Starting Price

Not publicly listed (quote-based)

Not publicly listed (enterprise)

Not publicly listed (bundled/enterprise)

Primary Users

China-based hospitals seeking multi-modality imaging assistance and vendor-reported NMPA-cleared modules

Hospitals that prioritize CT lung CAD with public regulatory documentation for some features

Health systems using United Imaging equipment seeking integrated AI across scanners/platforms

Key Strength

Vendor-stated broad modality support and end-to-end workflow features

Public regulatory signaling for some CT lung features (e.g., references to regulatory clearances)

Equipment-plus-software ecosystem that can simplify integration for standardized fleets

Key Weakness

Limited publicly accessible third-party review corpus and limited public security/compliance disclosures

Enterprise procurement complexity and modular focus may require combining vendors for multi-modality needs

Potential vendor lock-in if buyer is not standardized on United Imaging devices

Yizhun Intelligent (医准智能)

01Competitive Landscape

Competitive Landscape

02Market Map

01Competitive Landscape

Competitive Landscape

02Market Map